| ABGNX | CLBAX | ABGNX / CLBAX | |
| Total Expense Ratio | 0.69 | 0.58 | 119% |
| Annual Report Gross Expense Ratio | 0.69 | 0.58 | 119% |
| Fund Existence | 9 years | 25 years | - |
| Gain YTD | 5.078 | 8.484 | 60% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 898M | 285B | 0% |
| Annual Yield % from dividends | 1.71 | 1.80 | 95% |
| Returns for 1 year | 6.88 | 6.67 | 103% |
| Returns for 3 years | 37.59 | 41.43 | 91% |
| Returns for 5 years | 5.98 | 33.22 | 18% |
| Returns for 10 years | N/A | 95.16 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JSEPX | 34.02 | 0.28 | +0.83% |
| JPMorgan Small Cap Equity R3 | |||
| STFGX | 150.53 | 1.17 | +0.78% |
| State Farm Growth | |||
| FCGYX | 20.76 | 0.14 | +0.68% |
| NYLIM PineStone Global Equity Class C | |||
| FSBKX | 23.59 | 0.09 | +0.38% |
| Federated Hermes Global Allocation R | |||
| PACDX | 11.54 | 0.02 | +0.17% |
| Franklin Dynamic Asset Allocation CnsvR5 | |||